Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.

Full Abstract

An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic cation transporters (OCTs) of the solute carrier family 22 (SLC22). Because interindividual variability of OCT expression may affect response to cationic drugs such as metformin, we systematically investigated genetic and nongenetic factors of OCT1/SLC22A1 and OCT3/SLC22A3 expression in human liver. OCT1 and OCT3 expression (messenger RNA [mRNA], protein) was analyzed in liver tissue samples from 150 Caucasian subjects. Hepatic OCTs were localized by way of immunofluorescence microscopy. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and genome-wide single-nucleotide polymorphism microarray technology served to genotype 92 variants in the SLC22A1-A3/OCT1-3 gene cluster. Transport of metformin by recombinant human OCT1 and OCT3 was compared using transfected cells. OCT1 mRNA and protein expression varied 113- and 83-fold, respectively; OCT3 mRNA expression varied 27-fold. OCT1 transcript levels were on average 15-fold higher compared with OCT3. We localized the OCT3 protein to the basolateral hepatocyte membrane and identified metformin as an OCT3 substrate. OCT1 and OCT3 expression are independent of age and sex but were significantly reduced in liver donors diagnosed as cholestatic (P < or = 0.01). Several haplotypes for OCT1 and OCT3 were identified. Multivariate analysis adjusted for multiple testing showed that only the OCT1-Arg61Cys variant (rs12208357) strongly correlated with decreased OCT1 protein expression (P < 0.0001), and four variants in OCT3 (rs2292334, rs2048327, rs1810126, rs3088442) were associated with reduced OCT3 mRNA levels (P = 0.03). CONCLUSION: We identified cholestasis and genetic variants as critical determinants for considerable interindividual variability of hepatic OCT1 and OCT3 expression. This indicates consequences for hepatic elimination of and response to OCT substrates such as metformin.

Author information

Author/s: Nies, Anne T (AT); Koepsell, Hermann (H); Winter, Stefan (S); Burk, Oliver (O); Klein, Kathrin (K); Kerb, Reinhold (R); Zanger, Ulrich M (UM); Keppler, Dietrich (D); Schwab, Matthias (M); Schaeffeler, Elke (E);

Affiliation: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Hepatology (Baltimore, Md.) (Hepatology), published in United States. (Language: eng)

Reference: 2009-Oct; vol 50 (issue 4) : pp 1227-40

Dates: Created 2009/10/05; Completed 2009/10/20;

PMID: 19591196, status: MEDLINE (last retrieval date: 10/20/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentIn: Hepatology. 2009 Oct;50(4):1014-6. (PMID: 19787812)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Biological Transport - physiology
Cholestasis - metabolism; pathology
European Continental Ancestry Group - genetics
Gene Frequency - genetics
Glucose - metabolism
Haplotypes - genetics
Hepatocytes - metabolism; pathology
Humans

Hypoglycemic Agents - pharmacokinetics
Liver - metabolism; pathology
Metformin - pharmacokinetics
Multivariate Analysis
Octamer Transcription Factor-1 - genetics; metabolism
Organic Cation Transport Proteins - genetics; metabolism
Polymorphism, Single Nucleotide - genetics
RNA, Messenger - metabolism

Associated Chemicals: Hypoglycemic Agents (0) ; Octamer Transcription Factor-1 (0) ; Organic Cation Transport Proteins (0) ; POU2F1 protein, human (0) ; RNA, Messenger (0) ; solute carrier family 22 (organic cation transporter), member 3 (0) ; Glucose (50-99-7) ; Metformin (657-24-9)

These are the highest related articles currently in the database: